NEW YORK ( TheStreet) -- TheStreet's Jim Cramer and "Mad Money" Research Director Nicole Urken were examing some growth stocks and how they might fit into investors' portfolios.

The first stock they looked at was Marketo ( MKTO), which focuses on reaching out to potential clients via email marketing. The company is similar to ExactTarget ( ET), which was just acquired by Salesforce.com ( CRM).

Cramer noted that Salesforce.com currently works with Marketo, but doesn't think the companies will continue to do business together because of the acquisition.

However, there could be value there for companies such as Microsoft ( MSFT) or SAP AG ( SAP) that might be looking to acquire an online marketing company.

Cramer said Medidata Solutions ( MDSO) is a company that focuses on using the cloud to help make biotech and health care companies more efficient. Instead of having to wait days to see the results of a current test, they can now see them as it is happening.

This helps dramatically improve the effectiveness and timeliness for a lot of companies. With many firms focusing on cutting costs and ratcheting up efficiency, this may be a good stock for investors to look at.

-- Written by Bret Kenwell in Petoskey, Mich.

Bret Kenwell currently writes, blogs and also contributes to Rocco Pendola's Weekly Options Newsletter. Focuses on short- to intermediate-term trading opportunities that can be exposed via options. He prefers to use debit trades on momentum setups and credit trades on support/resistance setups. He also focuses on building long-term wealth by searching for consistent, quality dividend paying companies and long-term growth companies. He considers himself the surfer, not the wave, in relation to the market and himself. He has no allegiance to either the bull side or the bear side.

If you liked this article you might like

Outsiders Led the Buyouts of Tech 'Unicorns' in 2016

SLB, WBA, DAL: Jim Cramer's Views

Cramer: Let's Review Salesforce's Hacked Shopping List

F5 Networks in Focus as Next Activist Target After Infoblox Deal

Symphony Technology Finds Harmony With Middle-Market Software Deals